Meeting
2018 ASCO Annual Meeting
Artificial intelligence methods to predict chemotherapy-induced neutropenia in breast cancer patients.
Authors
Peter Abdul DeWan
Precision Health Ai, New York, NY
Peter Abdul DeWan , Orr Inbar , Catherine S. Spina , Karl Rudeen , Charles Lagor , Mark S. Walker , Edward J. Stepanski , Jennifer O. Nwankwo , Brigham Hyde
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research, Clinical Informatics, and Quality of Care
Track
Quality Care/Health Services Research
Sub Track
Clinical Informatics
Citation
J Clin Oncol 36, 2018 (suppl; abstr 6555)
DOI
10.1200/JCO.2018.36.15_suppl.6555
Abstract #
6555
Poster Bd #
381
Abstract Disclosures
Similar Posters
Poster
2012 Breast Cancer Symposium
Adjuvant chemotherapy for early-stage breast cancer: Choice of regimen and associated hematologic toxicities in a metropolitan Australian hospital.
First Author: Katherine Lovat
Poster
2011 ASCO Annual Meeting
Multigene predictors developed on breast cancer cell lines to predict patient chemotherapy response: A validation study on the NSABP B-27 trial.
First Author: K. Shen
Poster
2023 ASCO Annual Meeting
Oral paclitaxel, carboplatin, and dostarlimab (OPE/Cb/D) without and with trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL.
First Author: Kay T Yeung
Poster
2022 ASCO Annual Meeting
Real-world effectiveness of prophylactic granulocyte colony-stimulating factor (G-CSF) early (week 1) and late (weeks 2-3) in the cycle for the prevention of febrile neutropenia (FN) among patients (pts) with breast cancer (BC) after high FN–risk chemotherapy (chemo).
First Author: Douglas W. Blayney